Search

Displaying results 9891 - 9900 of 10000 in total
  1. Drug

    Deuremidevir

    go.drugbank.com/drugs/DB26606
    Investigational

    Deuremidevir is under investigation in clinical trial NCT06328400 (A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension).

  2. Drug

    Cyclic adenosine monophosphate

    go.drugbank.com/drugs/DB02527
    Investigational

    Cyclic adenosine monophosphate (cAMP, cyclic AMP or 3'-5'-cyclic adenosine monophosphate) is a molecule that is important in many biological processes; it is derived from adenosine triphosphate (ATP).

  3. Drug

    Cycloleucine

    go.drugbank.com/drugs/DB04620
    Experimental

    It is also a specific and reversible inhibitor of nucleic acid methylation and widely used in biochemical experiments.

  4. Drug

    Dextofisopam

    go.drugbank.com/drugs/DB06582
    Investigational

  5. Drug

    Omiganan

    go.drugbank.com/drugs/DB06610
    Investigational

    Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.

  6. Drug

    AB192

    go.drugbank.com/drugs/DB06111
    Experimental

    AB192 is a DPP IV enzymatic activity inhibitor.

  7. Drug

    GW-559090

    go.drugbank.com/drugs/DB06508
    Experimental

  8. Drug

    Edaglitazone

    go.drugbank.com/drugs/DB06519
    Investigational

  9. Drug

    Tramiprosate

    go.drugbank.com/drugs/DB06527
    Investigational

  10. Drug

    Esmirtazapine

    go.drugbank.com/drugs/DB06678
    Investigational

    Esmirtazapine, known by the standardized identifier SCH 900265, was under development by Organon to treat insomnia and vasomotor symptoms associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses sim...